Unnamed: 0,title,date,stock,sentiment
302355.0,CryoLife Reports Initiation Of Enrollment In PROACT Xa Trial,2020-05-07 16:23:00-04:00,CRY,neutral
302356.0,"Cryolife Q1 EPS $(0.080) Misses $0.020 Estimate, Sales $66.429M Beat $66.420M Estimate",2020-04-30 16:26:00-04:00,CRY,negative
302357.0,10 Biggest Price Target Changes For Thursday,2020-04-02 08:10:00-04:00,CRY,neutral
302358.0,"Needham Maintains Buy on Cryolife, Lowers Price Target to $29",2020-04-02 06:52:00-04:00,CRY,negative
302359.0,CryoLife Sees Q1 Sales ~$65.5M vs $68.4M Estimate,2020-04-01 16:03:00-04:00,CRY,neutral
302360.0,CryoLife Reports Implement Of 4 Initiatives In Response To Coronavirus,2020-04-01 16:02:00-04:00,CRY,neutral
302361.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,CRY,negative
302362.0,CryoLife Reports Receives CE Mark For E-vita Open NEO Stent Graft,2020-03-04 16:07:00-05:00,CRY,neutral
302363.0,CryoLife Reports CE Mark For On-X Prosthesis,2020-02-27 16:27:00-05:00,CRY,neutral
302364.0,76 Biggest Movers From Friday,2020-02-18 05:13:00-05:00,CRY,neutral
302365.0,"Canaccord Genuity Downgrades Cryolife to Hold, Lowers Price Target to $29",2020-02-14 11:53:00-05:00,CRY,negative
302366.0,CryoLife Sees FY20 Sales Of $292M-$298M,2020-02-13 16:17:00-05:00,CRY,neutral
302367.0,"Cryolife Q4 EPS $0.1 Beats $0.08 Estimate, Sales $69.7M Miss $70.82M Estimate",2020-02-13 16:16:00-05:00,CRY,negative
302368.0,10 Biggest Price Target Changes For Wednesday,2020-01-29 08:11:00-05:00,CRY,neutral
302369.0,"Needham Maintains Buy on Cryolife, Raises Price Target to $38",2020-01-29 06:11:00-05:00,CRY,neutral
302370.0,CryoLife Receives FDA Authorization To Commence PROACT Xa Clinical Trial,2019-12-23 08:43:00-05:00,CRY,neutral
302371.0,CryoLife And Misonix Enter Into Distribution Agreement For NeoPatch,2019-12-19 08:40:00-05:00,CRY,positive
302372.0,"Benzinga's Top Upgrades, Downgrades For December 11, 2019",2019-12-11 10:46:00-05:00,CRY,positive
302373.0,Needham Upgrades Cryolife to Buy,2019-12-11 06:59:00-05:00,CRY,neutral
302374.0,CryoLife Receives CE Mark for E-nya Thoracic Stent Graft,2019-12-02 08:04:00-05:00,CRY,neutral
302375.0,"Oppenheimer Initiates Coverage On Cryolife with Outperform Rating, Announces $34 Price Target",2019-10-22 06:10:00-04:00,CRY,neutral
302376.0,Stocks That Hit 52-Week Lows On Thursday,2019-10-10 11:08:00-04:00,CRY,negative
302377.0,Stocks That Hit 52-Week Lows On Wednesday,2019-10-09 12:55:00-04:00,CRY,negative
302378.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-08 12:02:00-04:00,CRY,negative
302379.0,CryoLife Acquires Exclusive European Distribution Rights to NEXUS Stent Graft System for Upfront Payment of $10M,2019-09-12 04:05:00-04:00,CRY,positive
302380.0,CryoLife Enters Into Distribution Agreement with Endospan; Co. Will Acquire Exclusive Distribution Rights To NEXUS And Will Have Option To Acquire Endospan,2019-09-11 16:04:00-04:00,CRY,positive
302381.0,cOCryolife Sees FY2019 EPS $0.28-0.32; Sees Sales $280M-284M,2019-07-30 16:48:00-04:00,CRY,neutral
302382.0,Cryolife Raises FY2019 EPS Guidance from $0.28-0.32 to $0.28-0.32; Raises FY2019 Sales Guidance from $280M-284M to $280M-284M,2019-07-30 16:46:00-04:00,CRY,neutral
302383.0,"Cryolife Q2 EPS $0.11 Beats $0.07 Estimate, Sales $71.139M Beat $70.79M Estimate",2019-07-30 16:44:00-04:00,CRY,neutral
302384.0,"CryoLife Reaffirms FY19 Adj. EPS $0.28-$0.32 vs $0.30 Estimate, Sales $280M-$284M vs $282.4M Est.",2019-04-30 17:14:00-04:00,CRY,neutral
302385.0,"Cryolife Q1 EPS $0.04, Inline, Sales $67.5M Beat $66.36M Estimate",2019-04-30 17:13:00-04:00,CRY,neutral
302386.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,CRY,positive
302387.0,"Benzinga's Top Upgrades, Downgrades For February 28, 2019",2019-02-28 09:14:00-05:00,CRY,positive
302388.0,Needham Initiates Coverage On Cryolife with Hold Rating,2019-02-28 07:00:00-05:00,CRY,neutral
302389.0,71 Biggest Movers From Yesterday,2019-02-15 04:59:00-05:00,CRY,neutral
302390.0,52 Stocks Moving In Thursday's Mid-Day Session,2019-02-14 12:27:00-05:00,CRY,neutral
302391.0,CryoLife Raises FY18 Adj. EPS $0.29-$0.32 To $0.30-$0.33 vs $0.32 Estimate,2018-10-31 17:07:00-04:00,CRY,neutral
302392.0,"CryoLife, Inc. Q3 EPS $0.08 Beats $0.07 Estimate, Sales $64.6M Beat $61.84M Estimate",2018-10-31 17:05:00-04:00,CRY,neutral
302393.0,48 Biggest Movers From Yesterday,2018-10-17 05:53:00-04:00,CRY,neutral
302394.0,40 Stocks Moving In Tuesday's Mid-Day Session,2018-10-16 12:46:00-04:00,CRY,neutral
302395.0,Mid-Day Market Update: Dow Rises Over 350 Points; Hanwha Q CELLS Shares Spike Higher,2018-10-16 12:19:00-04:00,CRY,positive
302396.0,CryoLife Sees Q3 Sales ~$64.6M vs $61.8M Estimate,2018-10-15 17:02:00-04:00,CRY,neutral
302397.0,"Stocks Which Set New 52-Week High Yesterday, September 25th",2018-09-26 11:53:00-04:00,CRY,neutral
302398.0,"Stocks Which Set New 52-Week High Yesterday, September 24th",2018-09-25 09:06:00-04:00,CRY,neutral
302399.0,"Cryolife Filing Shows Registration For Mixed Securities Offering, No Size Disclosed",2018-09-21 16:09:00-04:00,CRY,neutral
302400.0,"Stocks Which Set New 52-Week High Yesterday, August 23rd",2018-08-24 09:11:00-04:00,CRY,neutral
302401.0,"Stocks Which Set New 52-Week High Yesterday, August 22nd",2018-08-23 10:51:00-04:00,CRY,neutral
302402.0,"Stocks Which Set New 52-Week High Yesterday, August 7th",2018-08-08 11:01:00-04:00,CRY,neutral
302403.0,"CryoLife Reaffirms FY18 Adj. EPS Outlook $0.29-$0.32 vs $0.30 Est., Raises Sales Outlook From $250M-$256M to $256M-$260M",2018-08-06 17:34:00-04:00,CRY,neutral
302404.0,"Cryolife Q2 Adj. EPS $0.10 Beats $0.07 Estimate, Sales $68.5M Beat $64.08M Estimate",2018-08-06 17:33:00-04:00,CRY,neutral
302405.0,"Stocks Which Set New 52-Week High Yesterday, July 26th:",2018-07-27 10:42:00-04:00,CRY,neutral
302406.0,"Stocks Which Set New 52-Week High Yesterday, July 25th",2018-07-26 11:00:00-04:00,CRY,neutral
302407.0,"Stocks Which Set New 52-Week High Yesterday, July 24th:",2018-07-25 12:14:00-04:00,CRY,neutral
302408.0,"CryoLife Sees FY18 Sales $250-$256M vs $252M Est., EPS $0.29-$0.32 vs $0.31 Est.; Q2 Sales $63-$65M vs $63.9M Est.",2018-05-02 17:43:00-04:00,CRY,neutral
302409.0,"Cryolife Q1 EPS $0.02, Inline, Sales $61.9M Beat $60.29M Estimate",2018-05-02 17:42:00-04:00,CRY,neutral
302410.0,"CryoLife Late Wed. Reported Q4 EPS $0.11, Inline, Sales $52.83M vs $47.65M Est.; Sees FY18 Sales $250M-$256M vs $254.66M Est.",2018-03-08 08:48:00-05:00,CRY,neutral
302411.0,CryoLife Reports Enrollment Of First Patients In BioGlue Trial In China,2017-11-06 17:04:00-05:00,CRY,neutral
302412.0,"CryoLife Reiterates FY17 Adj. EPS Outlook At $0.40-$0.43 vs $0.42 Est.; Lowers FY17 Sales Outlook From $188M-$192M to $184M-$185M vs $188.07M Est.,",2017-10-30 17:32:00-04:00,CRY,negative
302413.0,"CryoLife Reports Q3 Adj. EPS $0.08 vs $0.09 Est., Sales $44M vs $45.65M Est.",2017-10-30 17:30:00-04:00,CRY,neutral
302414.0,28 Stocks Moving In Wednesday's Mid-Day Session,2017-10-11 12:19:00-04:00,CRY,neutral
302415.0,CryoLif To Acquire JOTEC For $225M,2017-10-10 17:01:00-04:00,CRY,neutral
302416.0,"CryoLife Sees FY17 Adj. EPS $0.40-$0.43 vs $0.43 Est., Sales $188M-$192M vs $189.3M Est.",2017-07-24 17:06:00-04:00,CRY,neutral
302417.0,"CryoLife Reports Q2 Adj. EPS $0.12 vs $0.10 Est., Sales $47.8M vs $47M Est.",2017-07-24 17:04:00-04:00,CRY,neutral
302421.0,20 Biggest Mid-Day Gainers For Thursday,2017-04-27 12:35:00-04:00,CRY,neutral
302422.0,"CryoLife Sees FY17 Adj. EPS $0.40-$0.43 vs $0.41 Est., Sales $188M-$192M vs $189M Est.",2017-04-26 17:05:00-04:00,CRY,neutral
302423.0,"CryoLife Reports Q1 Adj. EPS $0.09 vs $0.04 Est., Sales $45.1M vs $44.6M Est.",2017-04-26 17:04:00-04:00,CRY,neutral
302424.0,Ladenburg Thalmann Upgrades Cryolife To Buy,2017-02-17 09:20:00-05:00,CRY,neutral
302425.0,22 Biggest Mid-Day Losers For Thursday,2017-02-16 12:54:00-05:00,CRY,negative
302426.0,"Cryolife Sees FY17 Adj. EPS $0.40-$0.43 vs $0.47 Est., Sales $188M-$192M vs $193.7M Est.",2017-02-15 17:27:00-05:00,CRY,neutral
302427.0,"Cryolife Reports Q4 Adj. EPS $0.12 vs $0.09 Est., Sales $45M vs $46.9M Est.",2017-02-15 17:26:00-05:00,CRY,neutral
302428.0,Canaccord Genuity Medical Technology And Diagnostics Forum Today,2016-11-17 09:56:00-05:00,CRY,neutral
302429.0,"CryoLife Increases Fy16 Guidance, Rev. $180-$182M To $181-$182.5M, EPS $0.32-$0.34 To $0.43-$0.45",2016-10-26 17:35:00-04:00,CRY,neutral
302430.0,CryoLife Raises FY16 Guidance,2016-10-26 17:35:00-04:00,CRY,neutral
302431.0,"CryoLife Reports Q3 EPS $0.13 vs. Est. $0.05, Rev. $45.3M vs. Est. $44.9M",2016-10-26 17:35:00-04:00,CRY,neutral
302432.0,18 Biggest Mid-Day Gainers For Tuesday,2016-07-26 12:36:00-04:00,CRY,neutral
302433.0,Benzinga's Volume Movers,2016-07-26 10:54:00-04:00,CRY,neutral
302434.0,"CryoLife Increases FY16 EPS From $0.29-$0.32 To $0.32-$0.34, Rev. From $178-$180M To $180-$182M",2016-07-25 17:35:00-04:00,CRY,neutral
302435.0,"CryoLife Reports Q2 Adj. EPS $0.13 vs $0.04 in Same Qtr. Last Year, Sales $47.1M",2016-07-25 17:35:00-04:00,CRY,neutral
302436.0,Lake Street Initiates Coverage on Cryolife at Buy,2016-06-15 11:44:00-04:00,CRY,neutral
302437.0,Cryolife Sells Off to Low of $11.68; May be Attributed to Downgrade at Ladenburg to Neutral,2016-04-28 12:43:00-04:00,CRY,negative
302438.0,"CryoLife Earlier Reported Q1 Adj. EPS $0.10 vs $0.00 Est., Sales $43M vs $41.3M Est.",2016-04-27 19:01:00-04:00,CRY,neutral
302439.0,"CryoLife Sees FY16 Adj. EPS $0.29-$0.32 vs $0.12 Est., Sales $178M-$180M vs $178M Est.",2016-04-27 17:35:00-04:00,CRY,neutral
302440.0,CryoLife Acquires PhotoFix for $2.3 Million Cash,2016-04-14 07:43:00-04:00,CRY,neutral
302441.0,CryoLife Exercises Right to Acquire PhotoFix From Genesee BioMedical for $2.3M,2016-04-14 06:41:00-04:00,CRY,neutral
302442.0,"Canaccord Genuity Initiates Coverage on Cryolife at Buy, Announces $14.00 PT",2016-04-13 06:00:00-04:00,CRY,neutral
302443.0,CryoLife To Sell HeRO Graft To Merit Medical Systems For $18.5M Cash,2016-02-04 08:08:00-05:00,CRY,positive
302444.0,"CryoLife Announces Definitive Agreement to Acquire On-X Life Technologies Holdings, Inc. - $130M Upfront - 70% Cash, 30% Crylife Stock",2015-12-22 16:25:00-05:00,CRY,positive
302445.0,CryoLife Reports Resolution of PerClot Litigation with Medafor Inc.,2015-11-17 16:43:00-05:00,CRY,negative
302446.0,"Cryolife Q3 EPS $0.10 vs $0.01 est, Revenue $36.7M vs $38.2M est, Sees FY EPS $0.09 to $0.11 vs -$0.02 est, Sees FY Revenue $146M to $148M vs $148m est",2015-10-27 06:56:00-04:00,CRY,neutral
302447.0,Filing from Cryolife Shows Registration for $150M Mixed Securities Shelf Offering,2015-08-05 17:25:00-04:00,CRY,positive
302448.0,"CryoLife Reports Q2 Adj EPS $0.03 Vs Est $0.00, Sales $35.5< Vs Est $35.57M",2015-07-28 08:07:00-04:00,CRY,neutral
302449.0,CryoLife Receives Expanded Indication For BioGlue In Japan Which Doubles Japanes Market Opportunity To $10M,2015-07-09 08:36:00-04:00,CRY,positive
302450.0,Cryolife Announces Change To Direct Sales Model In France,2015-06-22 17:04:00-04:00,CRY,neutral
302451.0,"First Analysis Initiates Coverage on Cryolife at Overweight, Announces $14.00 PT",2015-05-18 05:29:00-04:00,CRY,negative
302452.0,"CryoLife Reports Q1 EPS -$0.01 Vs Est $0.00, Sales $33.8M vs Est $36.55M",2015-04-28 08:04:00-04:00,CRY,neutral
302453.0,CryoLife Announces Enrollment of First Patient in PerClotÂ® IDE Clinical Trial,2015-04-28 07:41:00-04:00,CRY,neutral
302454.0,CryoLife Announces First Patient Enrolled in PerClot IDE Clinical Trial,2015-04-28 07:35:00-04:00,CRY,neutral
302455.0,5 NYSE Healthcare Stocks With The Highest EPS Growth Forecast For Next 5 Years,2015-04-10 09:19:00-04:00,CRY,positive
302456.0,"CryoLife Announces Retirement of Founder, Chair Steven Anderson; Pat Mackin Named as Replacement",2015-04-10 08:34:00-04:00,CRY,neutral
302457.0,CryoLife Updates PerClot Litigation,2015-03-12 08:38:00-04:00,CRY,negative
302458.0,"Cryolife Sees FY 2015 Sales $151M to $153M, EPS -$0.03 to $0.00",2015-02-17 06:37:00-05:00,CRY,neutral
302459.0,"Cryolife Q4 EPS $0.04 vs $0.05, Sales $37.2M vs $37.4M",2015-02-17 06:34:00-05:00,CRY,neutral
302460.0,"Earnings Scheduled For February 17, 2015",2015-02-17 04:46:00-05:00,CRY,neutral
302461.0,Top 4 Small-Cap Stocks In The Medical Appliances & Equipment Industry With The Highest Dividend Yield,2015-02-10 04:36:00-05:00,CRY,positive
302462.0,Benzinga's Volume Movers,2014-12-23 10:47:00-05:00,CRY,neutral
302463.0,Benzinga's Top Upgrades,2014-12-23 08:52:00-05:00,CRY,positive
302464.0,Piper Jaffray Upgrades CryoLife To Overweight,2014-12-23 07:23:00-05:00,CRY,negative
302465.0,"Piper Jaffray Upgrades Cryolife to Overweight, Raises PT to $15.00",2014-12-23 05:50:00-05:00,CRY,negative
302466.0,"CryoLife, Inc. Reports Q3 EPS of $0.08 vs $0.05 Est; Revenue of $37.07M vs $37.72M Est; Raises FY14 GAAP EPS Guidance to $0.22-$0.24, Sales of $144-$146M Reaffirmed",2014-10-28 08:06:00-04:00,CRY,neutral
302467.0,Pat Mackin Joins CryoLife Board Of Directors,2014-10-22 08:34:00-04:00,CRY,neutral
302468.0,"CryoLife Announces Acquisition of Distribution Rights for PhotoFix, Terms Not Disclosed",2014-08-07 08:35:00-04:00,CRY,neutral
302469.0,"CryoLife, Inc. Reports Q2 EPS of $0.08 vs $0.05 Est; Revenue of $34.70M vs $35.72M Est",2014-07-24 08:04:00-04:00,CRY,neutral
302470.0,CryoLife Appoints Pat Mackin as President And CEO,2014-07-10 08:01:00-04:00,CRY,neutral
302471.0,10 U.S. Stocks With Strong Balance Sheets: Investment Idea Of The Day,2014-05-30 15:27:00-04:00,CRY,positive
302472.0,CryoLife Increases Quarterly Cash Dividend 9% to $0.03 per share from $0.0275,2014-05-22 17:04:00-04:00,CRY,positive
302473.0,"CryoLife, Inc. Reports Q1 EPS of $0.04 vs $0.07 Est",2014-04-29 08:14:00-04:00,CRY,neutral
302474.0,CryoLife Receives FDA Clearance for PerClot Topical Hemostatic Powder in the U.S. ,2014-04-29 08:06:00-04:00,CRY,neutral
302475.0,Morning Market Movers,2014-04-02 09:40:00-04:00,CRY,neutral
302476.0,"Cryolife Receives FDA Approval to Begin Trials for Perclot in US, Sees Enrollment in Q2",2014-04-02 08:33:00-04:00,CRY,positive
302477.0,"Cryolife Announces Purchase of Distribution Rights, Buy Option for ProCol, Will Reimburse Up to $2.3M of Production Costs",2014-03-27 08:35:00-04:00,CRY,neutral
302478.0,"Small Cap Movers for Feb. 20: UNTD, MCHX, AAOI, MEET, PATK, BIOL, GALE, LOPN Higher, FCN, CRY, EIG, IFT Lower",2014-02-20 13:15:00-05:00,CRY,negative
302479.0,"CryoLife, Inc. Sees FY2014 EPS $0.21-0.24 vs $0.38 Est",2014-02-20 08:12:00-05:00,CRY,neutral
302480.0,"CryoLife, Inc. Reports Q4 EPS of $0.31 vs $0.35 Est; Revenue of $35.50M vs $34.91M Est",2014-02-20 08:05:00-05:00,CRY,neutral
302481.0,CryoLife Says Will Receive ~$15.1M Related to Purchase of Medafor by CR Bard,2013-10-07 08:37:00-04:00,CRY,neutral
302482.0,"CryoLife, Inc. Lowers FY2013 EPS Guidance from $0.25-0.28 to $0.24-0.27 vs $0.28 Est",2013-07-25 08:06:00-04:00,CRY,negative
302483.0,"Cryolife Lowers FY Sales, EPS Outlook",2013-07-25 08:05:00-04:00,CRY,negative
302484.0,"CryoLife, Inc. Reports Q2 EPS of $0.08; Revenue of $33.52M vs $35.45M Est",2013-07-25 08:04:00-04:00,CRY,neutral
302485.0,SLIDESHOW: The Transformer Portfolio That Outperformed the S&P 500,2013-07-23 15:13:00-04:00,CRY,neutral
302486.0,CryoLife Wins FDA Premarket Approval for New Sologrip Minimally Invasive TMR Laser FO Delivery System,2013-07-10 08:35:00-04:00,CRY,positive
302487.0,CryoLife Receives Conditional IDE Approval to Begin Clinical Trials for PerClot in the U.S.,2013-06-19 08:35:00-04:00,CRY,positive
302488.0,Cryolife Wins CE Mark for Hero Graft,2013-06-10 08:34:00-04:00,CRY,positive
302489.0,"CryoLife, Inc. Reports Q1 EPS of $0.08 vs $0.07 Est; Revenue of $35.50M vs $35.04M Est",2013-04-30 08:04:00-04:00,CRY,neutral
302490.0,CryoLife Receives FDA Clearance For Next Generation HeRO Device,2013-04-04 08:35:00-04:00,CRY,positive
302491.0,Cryolife Expands Buyback Plan to $15M,2013-02-14 08:27:00-05:00,CRY,positive
302492.0,CryoLife Expands Stock Repurchase Program,2013-02-14 08:26:00-05:00,CRY,positive
302493.0,"CryoLife, Inc. Reports Q4 EPS of $0.08 vs $0.05 Est; Revenue of $32.80M vs $33.58M Est",2013-02-14 08:05:00-05:00,CRY,neutral
302494.0,Cryolife Wins Expanded Indication for BioFoam in Europe,2012-12-05 08:41:00-05:00,CRY,positive
302495.0,Cryolife Initiates Dividend of $0.025 per Share,2012-08-21 08:40:00-04:00,CRY,positive
302496.0,"The Benchmark Company Downgrades CryoLife from Buy to Hold, Lowers PT to $6",2012-08-06 07:05:00-04:00,CRY,negative
302497.0,"Cryolife Guides FY Revenue $129-133M, Had Seen $126-129M",2012-07-31 08:07:00-04:00,CRY,neutral
302498.0,CORRECT: CryoLife Reports Q2 EPS $0.10 vs $0.03 Est; Revenues $33.2M vs $32.79M Est,2012-07-31 08:06:00-04:00,CRY,neutral
302499.0,CryoLife Reports Q2 EPS $0.12 May Not Compare to $0.03 Est; Revenues $33.2M vs $32.79M Est,2012-07-31 08:05:00-04:00,CRY,neutral
302500.0,"CryoLife Announces Settlement of Patent Litigation with CardioFocus, Will Pay $4.5M",2012-06-14 17:07:00-04:00,CRY,negative
302501.0,Five Stocks With Heavy Insider Trading,2012-06-11 13:40:00-04:00,CRY,neutral
302502.0,"Benchmark Reiterates Buy Rating, $7.50 PT for CryoLife",2012-06-11 10:55:00-04:00,CRY,neutral
302503.0,Cryolife Holders Fail to Approve Executive Compensation Plan,2012-05-21 16:55:00-04:00,CRY,negative
302504.0,"Ladenburg Thalmann Reiterates Buy Rating, $7.75 PT for CryoLife",2012-05-16 11:37:00-04:00,CRY,neutral
302505.0,CryoLife to Acquire Hemosphere for $17M  ,2012-05-15 08:04:00-04:00,CRY,neutral
302506.0,CryoLife Reports Q1 EPS $0.04 vs $0.05 Est; Revenues $32.3M vs $31.13M Est,2012-04-26 08:06:00-04:00,CRY,neutral
302507.0,"Ladenburg Thalmann Initiates Coverage on CryoLife at Buy, Announces PT of $7.75",2012-04-24 09:14:00-04:00,CRY,neutral
302508.0,UPDATE: Benchmark Raises PT to $7.50 on CryoLife,2012-02-17 11:51:00-05:00,CRY,neutral
302509.0,"The Benchmark Company Maintains CryoLife at Buy, Raises PT from $6.5 to $7.5",2012-02-17 06:50:00-05:00,CRY,neutral
302510.0,CryoLife Reports Q4 EPS $0.07 vs $0.06 Est; Revenues $30.40M vs $31.12M Est	 			,2012-02-16 08:04:00-05:00,CRY,neutral
302511.0,Weekly Homework: Wipe The 2011 Slate Clean (With Economic Calendar and Stock Radar),2012-01-02 20:38:00-05:00,CRY,positive
302512.0,Weekly Homework: Are Bonds Trying To Tell Us Something? (w/ Economic Calendar & Stock Radar),2011-12-18 23:28:00-05:00,CRY,neutral
302513.0,CryoLife Expands Stock Repurchase Program to $15M,2011-11-01 08:35:00-04:00,CRY,positive
302514.0,"CryoLife Closes $20 Million Credit Facility with GE Capital, Healthcare Financial Services",2011-10-31 08:34:00-04:00,CRY,positive
302515.0,CryoLife Reports Q3 EPS $0.08 vs $0.08 Est; Revenues $29.7M vs $30.64M Est			,2011-10-27 08:51:00-04:00,CRY,neutral
302516.0,CryoLife Initiates Enrollment in U.S. Clinical Trial for BioFoam,2011-10-24 08:34:00-04:00,CRY,neutral
302517.0,"Edwards Lifesciences Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",2011-10-14 17:50:00-04:00,CRY,negative
302518.0,"Earnings Preview: Intuitive Surgical's EPS, Revenue Expected to Rise",2011-10-14 10:19:00-04:00,CRY,neutral
302520.0,Benzinga's Top Upgrades,2011-07-29 07:09:00-04:00,CRY,positive
302521.0,"Benchmark Upgrades Cryolife To Buy, $6.50 PT",2011-07-29 05:50:00-04:00,CRY,neutral
302522.0,CryoLife Invests $3.5M in ValveXchange,2011-07-07 08:36:00-04:00,CRY,neutral
302523.0,CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation (CRY),2011-05-06 08:52:00-04:00,CRY,positive
302524.0,CryoLife Reports EPS of $0.09 vs. $0.08 Estimate; Revenues $30.2M vs. $30.56M Estimate,2011-04-28 08:10:00-04:00,CRY,neutral
302525.0,Cryolife Guides 2011 EPS $0.26-$0.30 (CRY),2011-04-28 08:10:00-04:00,CRY,neutral
302526.0,CryoLife Launches BioGlue Surgical Adhesive in Japan ,2011-04-25 08:36:00-04:00,CRY,neutral
302527.0,CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation,2011-04-18 08:34:00-04:00,CRY,neutral
302528.0,"CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation, To Acquire 49.9% (CRY)",2011-04-15 16:36:00-04:00,CRY,neutral
302529.0,CryoLife Commences Tender Offer for All Outstanding Shares of Cardiogenesis Corporation,2011-04-05 08:38:00-04:00,CRY,positive
302530.0,CryoLife Files Investigational Device Exemption to Begin Clinical Trials for PerClot in the U.S. ,2011-04-04 08:35:00-04:00,CRY,neutral
302531.0,Benchmark Reports On CRY Intentions To Acquire CGCP,2011-03-30 09:08:00-04:00,CRY,negative
302532.0,CryoLife to Acquire Cardiogenesis for $22M,2011-03-29 07:52:00-04:00,CRY,neutral
302533.0,CryoLife Reports Q4 EPS of $0.08 vs. $0.07,2011-02-17 08:05:00-05:00,CRY,neutral
302534.0,A Peek Into The Market Before The Trading Starts,2010-12-01 08:09:00-05:00,CRY,neutral
302535.0,Piper Jaffray Maintains Neutral On CryoLife (CRY),2010-12-01 07:46:00-05:00,CRY,neutral
302536.0,CryoLife Posts Record Third Quarter Revenues of $28.4 Million; EPS of $0.07,2010-11-04 08:05:00-04:00,CRY,neutral
302537.0,CryoLife Receives Japanese Regulatory Approval ,2010-10-07 08:35:00-04:00,CRY,positive
302538.0,David P. Lang Appointed Vice President of CryoLife ,2010-10-04 08:36:00-04:00,CRY,neutral
302539.0,Piper Jaffray Neutral On CryoLife  (CRY),2010-09-29 06:47:00-04:00,CRY,neutral
302540.0,CryoLife Enters into Worldwide Distribution and Manufacturing Agreements ,2010-09-28 16:33:00-04:00,CRY,positive
302541.0,CryoLife CryoPatch Gets Extension - Analyst Blog,2010-08-11 16:06:00-04:00,CRY,neutral
302542.0,"Top 5 NYSE Stocks In the Healthcare Sector With The Highest 5-Y Earnings Estimates (PRX, CRY, TCM, VRX, MR)",2010-03-03 08:40:00-05:00,CRY,negative
302543.0,Cryolife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam (CRY),2009-10-27 08:38:00-04:00,CRY,positive
302544.0,CryptoLogic Licenses Innovative Betting Games to Ladbrokes,2009-08-17 02:00:00-04:00,CRY,positive
302545.0,CryptoLogic Shows Growth in Core Businesses in Q2,2009-08-13 02:00:00-04:00,CRY,positive
